⏳ This feels like the final signal before the next major chapter begins. When the company itself says shareholders are about to get “a closer look” and that this is “the beginning of something much bigger,” people should probably pay attention. This isn’t just a post. This is momentum building. This is infrastructure, relationships, technology, biotech, pharmaceutical science, and digital capital all starting to converge. Protxtm.com The world needs to see what’s coming. $TXTM #TXTM #ProtextMobility #FutureInfrastructure #Biotechnology #PharmaceuticalScience #DigitalCapital #RWA #Tokenization #RealWorldAssets #OTCStocks #OTCMarkets #Uplist #Shareholders #TXTMTribe

Shoutout to @gs121568 for pointing this out because I’ll admit it… I was focused heavily on the SeedVault, IFRS, uplist path, Kettle Tech, and biological asset… But the bigger architecture may be even larger than I originally looked at it. $TXTM is not just talking about tokenizing assets. The company’s video lays out a full RWA infrastructure model: Physical APIs / biological assets → RWA Platform → Interchangeable fiat → Digital tokens → New revenue streams That is not a simple product sales model. That is biological/pharmaceutical assets being transformed into digital financial infrastructure. This connects everything TXTM has been building: Kettle Tech live plant extraction = premium physical/API assets Nanotech enhanced processing = very high bioavailability and product value SeedVault / biological inventory = asset base IFRS audits valuation = institutional recognition Custodial/banking rails = capital movement and settlement RWA platform = liquidity and monetization layer Major exchange/uplist path = institutional access and price discovery The key distinction is this: If TXTM only tokenized its own assets, that would already be significant. But if TXTM controls the RWA platform layer, that changes the model completely. Then they are not only an asset holder. They become infrastructure. That opens the door to multiple potential revenue paths: asset backed tokenization, platform fees, custody/settlement rails, fiat/digital liquidity flows, third party asset onboarding, API monetization, potential SPV/white label structures, and cross border capital access. This is why IFRS, independent valuation, institutional custodial architecture, ABSA/BNY/Melville/Standard Bank references, RWA tokenization, and the major exchange roadmap all matter. They are not separate storylines. They are one full stack capital architecture. The “Physical APIs → RWA Platform → Interchangeable Fiat / Digital Tokens” graphic is the whole thesis in one image. It shows the asset layer, the platform layer, and the liquidity layer. That means the APIs are not just products. They can become monetizable real world assets. And the platform layer is where the real multiple expansion can happen when the company executes. My updated view: $TXTM appears to be positioning itself as a biological/pharmaceutical asset company with an RWA/tokenization infrastructure layer. Not simply a product company. Not simply a seed story. Not simply “putting assets on blockchain.” Assets platform liquidity rails exchange access. That is the architecture. #TXTM #TXTMTribe #ProTextMobility #RWA #RWATokenization #Tokenization #RealWorldAssets #DigitalAssets #DigitalInfrastructure #Blockchain #OnChain #DeFi #TradFi #FinTech #Pharma #Biotech #APIs #KettleTech #Nanotechnology #IFRS #Uplist #OTCMarkets #OTCStocks #Microcaps #CapitalMarkets #InstitutionalInvesting #AssetBacked #Liquidity #SeedVault x.com/Dr_Jamaloodeen/status/…

protxtm.com Bashers keep on talking about “valuations” like $TXTM pulled numbers out of thin air. Let me remind YOU. That is not what happened. The company has already completed IFRS audited financials for 2022 and 2023, with 2024 in progress and 2025 expected to follow the same path. And most importantly: $TXTM has already stated it is administratively compliant and positioned for a major global exchange uplist. I repeat MAJOR (Not OTC). That is company disclosed language. (See Attached) Auditors do not just let a company pick whatever number it wants. Auditors rely on independent valuation work, documentation, accounting standards, and the proper financial framework for the market being pursued. That is the difference between a random valuation opinion and audited financials. $TXTM did not just talk about it. They built toward it. Promises made. Promises kept. ✅ CE removed ✅ OTCiD achieved ✅ IFRS audited 2022 and 2023 financials completed ✅ 2024 IFRS audit in progress ✅ Already administratively compliant for a major global exchange uplist ✅ New investor relations portal ✅ New corporate website launched ✅ Technical and digital infrastructure advancing ✅ TruLeaf LOI disclosed ✅ Voluntary EDGAR submissions ✅ Form 10 / SEC compliance direction still in play ✅ Global exchange positioning clearly stated And now that the website is live, the next phase becomes a lot more visible. The bashers can cry about valuations all they want, but big business does not move based on message board emotions. It moves on audits. It moves on compliance. It moves on assets. It moves on structure. It moves on execution. That is what $TXTM has been quietly putting together in the background. The company said it was building toward something bigger. Now the pieces are showing up one by one. So keep laughing from grandma’s basement if you want. When $TXTM is no longer sitting where it is today, don’t say the signs were not there. They were. Some people just chose not to read them. $TXTM protxtm.com #TXTM #ProtextMobility #Protext #OTCMarkets #OTCID #IFRS #IFRSAudited #AuditedFinancials #GlobalExchange #MajorExchangeUplist #Uplist #Form10 #EDGAR #SECCompliance #InvestorRelations #PromisesMadePromisesKept #BiologicalAssets #RealWorldAssets #RWA #Tokenization #DigitalInfrastructure #PharmaceuticalInfrastructure #CBDAPI #TruLeaf #BRICS #JSE #GlobalMarkets #NoReverseSplit #NoDilution #OTCStocks #PennyStocks #StockMarket #DueDiligence #DD

$TXTM Website / IR Suite Breakdown The new ProText Mobility website is not just a cosmetic refresh. It represents a major shift in how the company is presenting itself to the market. For years, many tried to frame $TXTM as a simple cannabis, hemp, or botanical company. That is clearly not the story anymore. The new website now positions ProText Mobility as an infrastructure company at the intersection of biology, pharmaceutical science, real-world assets, API development, and digital capital markets. This is no longer just about growing plants. It is about building a vertically integrated platform: Biological production Controlled cultivation Genetic propagation Live plant extraction API engineering Molecular stabilization KettleTech RWA / tokenized infrastructure That matters because serious markets do not value ideas. They value assets, systems, infrastructure, compliance pathways, and scalable commercial models. The website now lays out several key layers: Expanded Strategic Vision $TXTM is presenting itself as a next-generation biological, pharmaceutical, and digital infrastructure platform. This moves the story beyond basic agriculture and into a more institutional infrastructure model. Science & API Infrastructure The site highlights controlled biological production, cultivation systems, regenerative farming, genetic propagation, molecular consistency, and pharmaceutical-grade API development. The key word is consistency. If the goal is pharmaceutical-grade output, the value starts at the biological source level. Live Plant Extraction The website gives more attention to live plant extraction. This is being framed around preserving phytochemical profiles, cannabinoid acids, molecular integrity, and reducing degradation from traditional extraction methods. In simple terms: Better preservation of the plant profile can support higher value API production. KettleTech KettleTech now has a clear public-facing role. The platform is being positioned around advanced thermal control, nano-emulsion processing, stabilization systems, and enhanced bioavailability. That matters because bioavailability is one of the biggest value drivers in pharma and nutraceutical markets. It is not just what compound you produce. It is how effectively the body can absorb and use it. Tokenization & Digital Assets The site gives more structure to the RWA/tokenization side. The important part is the order of operations. $TXTM is not presenting tokenization as the first layer. It is presenting tokenization as the downstream layer after the biological, pharmaceutical, and infrastructure layers are established. You do not tokenize air. You tokenize verified assets, inventory, production systems, infrastructure, and future economic value. That distinction matters. Why the Website Had to Come First You do not roll out major filings, valuation work, audits, investor decks, global exchange updates, banking structures, or tokenized asset infrastructure while sending new investors to an outdated website. The website is the front door. The IR suite is the document room. The deck is the story. The filings and PRs are the proof. That is why this had to happen first. My takeaway: The website is not the finish line. It is the launchpad. $TXTM is no longer presenting itself as a small OTC botanical story. It is presenting itself as a biological pharmaceutical and digital infrastructure company built around real world assets, API development, proprietary technology, and tokenized capital markets. That is the shift. That is why the website matters. And that is why the next official company updates matter even more. Pay attention for what happens NEXT. #TXTM #ProTextMobility #RWA #Tokenization #DigitalAssets #Biotech #Pharma #API #IFRS #Uplist #OTCMarkets #Web3 #RealWorldAssets #KettleTech #CBD #Hemp #Investing

The new $TXTM protxtm.com website and presentation decks make the bigger picture clear. This is no longer being presented as just an OTC cannabis story. Protext Mobility is positioning itself as an infrastructure company operating at the convergence of: Biology Pharmaceutical science API engineering Nanotechnology Real-world assets Tokenization Digital capital markets Global liquidity systems The Master Institutional Deck lays out the full thesis: Biological inventory → API engineering → digital asset infrastructure. The Live Plant Extraction Deck shows the science engine behind it: Molecular preservation Full spectrum retention Nano-enhanced bioavailability Pharmaceutical-grade API focus High value API engineering TruLeaf Health integration This is the bridge: Biological assets become pharmaceutical infrastructure. Pharmaceutical infrastructure becomes tokenizable RWA infrastructure. RWA infrastructure connects to global capital markets. That is the evolution of $TXTM. Engineering the infrastructure layer between biology, pharmaceutical science, and digital capital. $TXTM #TXTM #ProtextMobility #Biotechnology #BioPharma #API #ActivePharmaceuticalIngredients #LivePlantExtraction #NanoTechnology #Bioavailability #TruLeaf #RWA #RealWorldAssets #Tokenization #DigitalAssets #Mainnet #IFRS #GlobalMarkets #Uplist #PriceDiscovery

Promises Made. Promises Kept. June 3rd marks one year since $TXTM had the Caveat Emptor designation removed. One year ago, $TXTM was restricted, questioned, doubted, and written off. Then CE was removed. The stock had closed at .0006 and opened around .0021, with June 3rd, 2025 delivering roughly a 1,000% move from where the market had priced it during suppression. That day was not just a trading day. It was the first real reminder that $TXTM survived what most OTC companies never make it through. And one year later, look at what has advanced: ✅ CE removed ✅ OTCiD upgraded ✅ Not Pink ✅ No reverse split ✅ No dilution ✅ No salary drain ✅ Zero debt direction ✅ Audits progressing ✅ PCAOB / IFRS work advancing ✅ Uplist path active ✅ IR suite modernization ✅ New corporate website launch imminent ✅ Biological asset valuation framework ✅ 1.9B cannabis sativa seeds disclosed ✅ 125,959,995 mg of APIs disclosed ✅ TruLeaf LOI / API contribution framework ✅ CBD / API pharmaceutical direction ✅ Kettle technology advancement ✅ Nano technology integration ✅ Major bioavailability increase ✅ Token roadmap ✅ RWA strategy ✅ Dashboard development ✅ Mainnet live ✅ ABSA pilot connection ✅ BNY / Melville institutional framework ✅ Ambassador / shareholder alignment ✅ 775M chairman stock commitment ✅ Zero sold ever ✅ Proper price discovery still ahead And this is before the market has fully digested the biological assets, IFRS valuation framework, TruLeaf API contribution, nano tech, kettle technology, digital infrastructure, tokenization model, RWA strategy, dashboard, mainnet, and global exchange direction. Most OTC companies would not have survived years under CE. $TXTM did. Now, one year later, the conversation is no longer about survival. It is about valuation, infrastructure, biological assets, APIs, nano tech, tokens, mainnet, uplisting, and global price discovery. The market saw what happened the day CE came off. But that was only the reaction to the restriction being lifted. The bigger story is what has been built since. The company has now disclosed both a massive seed inventory and a significant API inventory, while also advancing the TruLeaf direction that connects CBD APIs, nano technology, bioavailability, and real-world asset valuation into the broader $TXTM framework. And with the upcoming website and IR suite launch, investors will begin to see a presentation of the company that goes over and above OTCiD requirements, a broader reflection of the execution, infrastructure, and direction that has continued advancing behind the scenes. Promises Made. Promises Kept. June 3rd is not just an anniversary. It is a reminder that $TXTM made it through the suppression phase. Now comes the recognition phase. Quiet today. Unstoppable tomorrow. $TXTM #TXTM #ProTextMobility #OTCiD #OTCMarkets #CaveatEmptorRemoved #Biotech #BioPharma #DigitalAssets #Tokenization #RWA #RealWorldAssets #Blockchain #Mainnet #NanoTech #CBD #API #TruLeaf #KettleTechnology #IFRS #PCAOB #Uplist #GlobalMarkets #PriceDiscovery #ShareholderAlignment #Execution #Infrastructure #NextPhase

🔥 $TXTM Protext Mobility Inc. delivers a powerful AI driven institutional presentation deck update! This master overview captures everything the company has been executing and communicating, from proprietary live plant extraction tech advancing cannabis medicines, to strategic uplisting progress, enhanced governance, EDGAR filings, insider alignment, and RWA/tokenization infrastructure positioning for the next level. Clear, professional, and built for institutional visibility. The vision is aligning with verifiable steps forward. Strong update that reinforces $TXTM’s trajectory. Worth watching: x.com/protextp/status/205782… #TXTM #ProtextMobility #Biotech #Uplisting #Innovation

People really need to understand the significance here. “Most do” The company’s last 8-K / SEC filing was in 2017 under old management. Now we are seeing voluntary EDGAR filings while the company is openly advancing beyond OTCID requirements. It shows a very different level of intent, structure, and seriousness than what this company had under prior management. With everything else going on, this is a massive signal that $TXTM is moving in a much bigger direction. All eyes open. #TXTM #ProTextMobility #ProtextPharma #EDGAR #SEC #8K #OTCMarkets #OTCID #Uplisting #Biotech #RWA #Tokenization #Blockchain #DigitalAssets #Shareholders

A lot of the reaction to this $TXTM PR falls into two buckets: The usual bashers who will dismiss anything no matter what is put in front of them, and the impatient crybabies who want every milestone instantly, on their timeline, or they act like nothing is happening. Meanwhile, a lot of this is unfolding right in front of their eyes. Also, TXTM is not framing itself here as a typical OTC name, it is explicitly positioning as a blockchain enabled asset tokenization company focused on compliant RWA solutions, which makes the liquidity, custody, and valuation language even more important. These 4 highlighted pages are not random fluff. They show a company communicating insider conviction, structural discipline, liquidity relationships, custodial wallet infrastructure, tokenization, proprietary tech, IFRS compliant audits, Deloitte linked price discovery, uplisting plans, hidden balance sheet value, forex tailwinds, and ESG integration. Page 1 shows conviction and discipline: Open ended stock purchases, no sales, no salaries from inception, no reverse split, zero debt language, named liquidity relationships, custodial wallet infrastructure, foreign direct trade / foreign equity flow, tokenization, proprietary kettle tech, and direct language about the disparity between current price and intrinsic value. Page 2 explains the engine: HULE as a reinvestment loop for balance sheet value, franchise growth, shareholder value, compounding returns, stock price appreciation, and scalable growth. It also ties tokenization, liquidity pathways, fiat/digital interchangeability, kettle tech, nano tech, APIs, and new revenue streams into one broader monetization model. Page 3 is the institutional roadmap: IR suite, voluntary EDGAR reporting, governance, transparency, IFRS compliant audited financials, Deloitte valuation for proper price discovery, major exchange uplisting, and direct language around unlocking hidden balance sheet value through IFRS treatment and the TruLeaf LOI. Page 4 adds the macro layer: forex tailwinds, profit potential, international expansion, carbon credits, ESG strategy, zero waste alignment, and long term shareholder value. So no, this is not “nothing.” And no, just because everything is not handed over overnight does not mean progress is not being made. Some people are too busy complaining that it is not happening fast enough to realize it is already taking shape. A large number of shareholders do see it. They appreciate the direction, they appreciate the work being done, and they understand that if this roadmap continues to unfold the way it is being communicated, the implications could be enormous. That is why this PR matters. Not because of one line. Because of the full picture. otcmarkets.com/stock/TXTM/ne… #TXTM #ProTextMobility #RWA #Tokenization #Blockchain #Biotech #IFRS #Deloitte #Uplisting #PriceDiscovery #HiddenValue #BalanceSheet #ESG #CarbonCredits #Liquidity #DigitalAssets #OTC #SmallCap #MicroCap #Investing

What @Dr_Jamaloodeen just pulled was a straight up Thomas Crown move. Silent. Precise. Elegant. Then out of nowhere he drops Blue Sky compliance, the full IR Suite, EDGAR alignment and flips the entire board in one shot. Nobody saw it coming. That’s what real leadership looks like, calculated timing, flawless execution, and zero wasted motion. Market makers, bashers, and anyone who thought they understood the playbook? They’re cooked. $TXTM is operating on a level the OTC has never seen before. #ProtextMobility #Tokenization #BlueSkyCompliance #IFRS #TXTM #RealWorldAssets #JSE #EDGAR

🚀 $TXTM Monumental Week: Shareholder Update Q3 Filing Unveils Blueprint for the Future Here’s everything that just changed the entire trajectory of this company 👇 📌 Shareholder Update (Nov 19) • Debt-free, no dilution, no reverse split. • $505 million balance sheet noted as debt-free. • IFRS-audited 2022 & 2023 financials complete, 2024 filings in progress toward PCAOB/Form 10 ambition. • Strategic support under the TruLeaf LOI recognized as IFRS income/gain (non-cash benefit to balance sheet). • FX tailwind opportunity via ZAR/USD translation on seed inventory. • New advisory board addition (Ambassador of Chad) to enhance global strategic depth. ⸻ 📌 Q3 Filing Highlights • Inventory – Genus Cannabis Sativa Seeds valued at $505 M. • Active Pharmaceutical Ingredients (API) inventory added (historical cost of ~$6.298M, FMV ~$10.71M). • Assets ~$511 M / Liabilities ~$0.7 M / Equity ~$510.6 M. • Seed-multiplication program confirmed: 600 M planted, 1 B returned, additional 250 M contributed. • Pilot-program LOI with ABSA Bank in South Africa: RWA tokenization, stablecoins, custodial walleting, APIs as collateral, carbon-credits inclusion, Ripple/XRP-rails. • The filing explicitly ties TXTM’s seed inventory API inventory → RWA → tokenization → new financial pathways. • Management working for $1/year; CEO bought 209 M common shares personally. • Operating expenses for the quarter: ~$4,404. ⸻ 🎯 Why This Matters More Than Ever This isn’t just business as usual. TXTM is now operating at the intersection of: • Next-gen biotech (live-plant extraction, kettle tech) • Pharmaceutical grade API development (Partnership) • Tokenized real-world assets (seeds, APIs, carbon credits) • Institutional finance (bank custody tokenization stablecoins) • Global regulatory alignment (IFRS, RWA accounting, International advisory board) DrJ has built the foundation, and now the monetization model can start to play out. The model: Biotech output → RWA asset valuation → tokenization/staking → scalable financial ecosystem. Bottom line: This is no longer just a seed-to-CBD play. It’s a full-blown biotech asset-finance global infrastructure. The market hasn’t yet internalized it. 11/19/25 Q3 👇🏼 otcmarkets.com/file/company/… 11/19/25 Shareholder Press Release 👇🏼 globenewswire.com/news-relea… #TXTM #Protext #ProtextMobility #TruLeaf #Biotech #PharmaTech #CBDAPI #CBDInnovation #FECO #Nanotechnology #Bioavailability #RWA #RealWorldAssets #Tokenization #Stablecoin #Blockchain #Fintech #DigitalAssets #IFRS #GAAP #PCAOB #Uplist #InternationalListing #ABSA #AfricaRising #Ripple #XRP #ACFTA #ShareholderValue #FutureFinance #NewPathways #GlobalHealing

🚀 $TXTM milestone! TruLeaf kettle tech = bioavailability boost & cheaper, faster CBD 🌱💊 API = real-world asset 💎 Potential stablecoin staking = new financial pathways! Exciting milestone for TXTM! TruLeaf’s nanotechnology perfectly complements TXTM’s kettle tech, dramatically improving bioavailability. Products are cheaper, faster-acting, and more effective, supporting patients and the mission of global healing. The resulting CBD API is a real-world asset on TXTM’s balance sheet, recognized as income/gain under IFRS/GAAP, with the potential to create a stablecoin that can be staked or invested, a transformative financial opportunity benefiting all shareholders. Combined with THC-free CBD FECO and Farm Bill compliance, TXTM now has regulatory compliance, competitive advantage, and shareholder value. 🔍 Key Highlights From Today’s TXTM × TruLeaf PR 1️⃣ Technological Synergy (The Foundation) •TruLeaf’s nanotechnology enhances TXTM’s kettle tech •Massive increase in bioavailability •Cheaper, faster, more effective CBD products •Direct boost to patient outcomes and shareholder value ⸻ 2️⃣ Regulatory & Competitive Advantage •TruLeaf’s CBD FECO is THC-free •Fully Farm Bill compliant •Gives TXTM regulatory clearance market differentiation This removes barriers to entering major U.S. and global markets. ⸻ 3️⃣ Financial Strengthening via RWA (Real-World Assets) •CBD API is recognized as a real-world asset •Classified under IFRS/GAAP as income/gain •No cash outflow needed to strengthen the balance sheet •Directly enhances net profit potential share price This is the accounting mechanism that changes the entire valuation model. ⸻ 4️⃣ New Financial Pathways (The Big One) •TXTM’s RWA CBD API can support creation of a stablecoin •Enables staking, liquidity, investment mechanics •A transformative financial innovation for tokenized biotech •Generates new revenue rails for all shareholders This is EXACTLY what DrJ has been saying for months. ⸻ 5️⃣ Market Validation & Mission Impact •TruLeaf is an established, successful partner, a vote of confidence •Accelerates growth, scaling, and market entry •Aligns perfectly with the TXTM Tribe mission: “Raising all boats.” ⸻ 📌 Bottom Line: This PR confirms the blueprint: Biotech output → RWA accounting → stablecoin → staking → scalable financial ecosystem. TXTM just opened the door to a hybrid biotech × tokenized finance model with global scalability #TXTM #Protext #ProtextMobility #TruLeaf #KettleTech #Nanotechnology #Bioavailability #CBDAPI #CBDInnovation #RealWorldAssets #RWA #Tokenization #Stablecoin #IFRS #GAAP #Biotech #Fintech #Blockchain #PharmaTech #PlantMedicine #GlobalHealing #ShareholderValue #NewPathways #FutureFinance

🚀 Big news: Protext Mobility (OTC: TXTM) has signed a Letter of Intent with TruLeaf (truleaf-health.com), launching a strategic partnership that could reshape CBD-nanotech. ✅ TruLeaf brings product samples, infrastructure & operational support. ✅ Their nanotech enhances TXTM’s kettle tech → better bioavailability, faster-acting, more cost-effective. ✅ Using THC-free CBD FECO Farm Bill compliance = strong regulatory edge. ✅ CBD API becomes a real-world asset on Protext’s balance sheet — potential for stablecoin, staking, liquidity innovation. ✅ This aligns with Protext’s mission: “raising all boats” — for patients, shareholders, and global healing. Not hype — just strategic innovation. Worth watching. 👀 #TXTM #ProtextMobility #TruLeaf #Biotech #CBD #Nanotech #Investing

🚀 Big news: Protext Mobility (OTC: TXTM) has signed a Letter of Intent with TruLeaf, kicking off a strategic partnership that could reshape how we think about CBD biotech. ✅ TruLeaf brings product samples, inventory, and operational support. ✅ Their nanotech boosts Protext’s kettle tech, meaning better bioavailability and efficiency. ✅ CBD FECO w/ zero THC Farm Bill alignment = regulatory edge. ✅ Even more: the partnership could unlock real-world assets (RWA) from CBD API — potentially recognized under IFRS/GAAP. ✅ There’s talk of future financial innovation — staking, stablecoin, new liquidity models. This isn’t just product synergy — it’s a step toward financial therapeutic innovation for TXTM. Worth keeping on your radar. 👀 #TXTM #ProtextMobility #biotech #CBD #nanotech #investing

$TXTM – Protext Mobility, Inc. Protext Mobility (OTC: TXTM) is stepping into a new phase with the launch of its next-generation investor relations platform and modernized corporate website — a move designed to bring greater transparency, communication, and accessibility to shareholders. This update reflects a broader commitment to growth, modernization, and investor engagement, positioning TXTM to better communicate its story and evolving business model to a wider audience. As the company continues to evolve, investors—both new and long-term—may want to keep an eye on TXTM’s progress as it builds toward its next chapter. #TXTM #ProtextMobility #Investing #OTCMarkets #Innovation #Transparency

👀 $TXTM is leveling up. Protext Mobility just kicked off the launch phase of its new Investor Relations platform and modernized website — built to bring more transparency, innovation, and trust to shareholders. #TXTM #ProtextMobility #OTCStocks #Investing #Transparency #Innovation #StockMarket #RetailInvestors

👀 $TXTM is leveling up. Protext Mobility just kicked off the launch phase of its new Investor Relations platform and modernized website — built to bring more transparency, innovation, and trust to shareholders. Full story 👉 prismmediawire.com/protext-m…… #TXTM #ProtextMobility #OTCStocks #Investing #Transparency #Innovation #StockMarket #RetailInvestors

$TXTM | Protext Mobility, Inc. Now entering its launch phase for a next-generation Investor Relations Suite and a modernized corporate website — marking a step forward in transparency, innovation, and shareholder communication. #TXTM #ProtextMobility #InvestorRelations #OTCStocks #Transparency #Innovation #ShareholderUpdates #MarketNews

$TXTM #ProTextMobility

$TXTM #ProTextMobility